ARCHIVES

PET Tracer Drug Approved, Developed At Weill Cornell

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

Major Emphasis Switch; Outreach Core Support Ends In Favor Of Cancer Control Research

January 22, 1982

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014